Orthofix Medical Inc. (OFIX)

NASDAQ: OFIX · USD

$10.0

+0.30 (+3.1%)· Recorded snapshot

Market cap	407.7M
Revenue (ttm)	833.2M
Net income (ttm)	-61.7M
EPS (ttm)	-$1.53
Shares out	40.7M
Volume	225,384
Beta	0.62

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 833.2M
Net income (ttm): -61.7M
EPS (ttm): -$1.53
Market cap: 407.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-13.9

P25 -113.8P50 -46.5P75 -0.9

ROIC-6.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All OFIX indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000884624
Company name	Orthofix Medical Inc.
Country	United States
Country code	US
CUSIP number	68752M108
Earnings date	2026-11-09
Earnings time	bmo
Employees	1,605
Employees change	-11
Employees growth	-0.68%
Enterprise value	$565.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US68752M1080
Last 10-K release date	2026-02-24
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$407.7M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$10.01
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	OFIX
U.S. state	Texas
Website	https://orthofix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	25.5x
Earnings yield	-15.31%
EV/EBITDA	26.94x
EV/Sales	0.68x
FCF / EV yield	-4.94%
FCF yield	-6.86%
Forward EV/Sales	0.65x
Forward P/S	0.47x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.92x
P/OCF ratio	24.94x
P/S ratio	0.49x
Price / tangible book value	2.41x
Price/EBITDA ratio	19.39x
Sector forward P/E	23.56x
Sector P/E	50.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.51%
EBITDA margin	2.51%
Gross margin	71.26%
Operating margin	-4.51%
Pretax margin	-7.24%
Profit margin	-7.41%
Profit per employee	$-38,457
Revenue per employee	$519,119
ROA	-2.75%
ROA (5Y)	-4.46%
ROCE	-5.25%
ROE	-13.91%
ROE (5Y)	-18.3%
ROIC	-6.45%
ROIC (5Y)	-10.2%
SBC / revenue	3.44%
Tax / revenue	0.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	5.57%
Gross profit growth (Q)	5.37%
Gross profit growth 3Y	11.92%
Gross profit growth 5Y	11.35%
Net income growth years	2
OCF growth	-43.23%
OCF growth 10Y	-11.63%
OCF growth 5Y	-18.21%
Revenue growth	2.99%
Revenue growth (Q)	3.85%
Revenue growth (QoQ)	7.23%
Revenue growth 10Y	7.39%
Revenue growth 3Y	11.66%
Revenue growth 5Y	12.83%
Revenue growth quarters	14
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-44.1M
Depreciation and amortization	$58.5M
EBIT	$-37.6M
EBITDA	$20.9M
EPS	$-1.53
FCF per share	$-0.68
Financing cash flow	$63.6M
Free cash flow	$-27.8M
Free cash flow minus SBC	$-56.5M
Gross profit	$593.7M
Income taxes	$1.4M
Investing cash flow	$-43.9M
Net borrowing	$63.6M
Net cash flow	$35.7M
Net income	$-61.7M
Operating cash flow minus SBC	$-12.4M
Operating income	$-37.6M
Revenue	$833.2M
Stock-based compensation	$28.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.27
Book value per share	$10.54
Debt / EBITDA	9.03
Debt / equity	0.61
Goodwill	$194.9M
Interest coverage	-1.81
Long-term assets	$426.9M
Long-term liabilities	$286.8M
Net cash (debt)	$-158.1M
Net cash / market cap	-38.97%
Net debt / EBITDA	7.55
Net debt / equity	0.37
Piotroski F-Score	5
Property, plant and equipment	$151.7M
Shareholders' equity	$429.2M
Tangible book value	$168.3M
Tangible book value per share	$4.13
Total assets	$873M
Total cash	$103.8M
Total debt	$261.9M
Total liabilities	$443.8M
WACC	7.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.97
Current assets	$446.1M
Current liabilities	$157M
Current ratio	2.84
Inventory turnover	1.34
Net working capital	$188.5M
Quick ratio	1.53
Working capital	$289.1M
Working capital turnover	3.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.56%
Dividend yield	0%
Shareholder yield	-3.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-73.38%
10Y return CAGR	-12.4%
10Y total return	-73.38%
150-day SMA	$10.53
15Y price change	-69.8%
15Y return CAGR	-7.67%
15Y total return	-69.8%
1D price change	3.09%
1M price change	6.04%
1M total return	6.04%
1W price change	2.77%
1W total return	2.77%
1Y price change	-37.75%
1Y return CAGR	-37.77%
1Y total return	-37.75%
20-day SMA	$9.49
200-day SMA	$11.15
20Y price change	-78.12%
20Y return CAGR	-7.32%
20Y total return	-78.12%
3M price change	-15.88%
3M total return	-15.88%
3Y price change	-6.8%
3Y return CAGR	-2.32%
3Y total return	-6.8%
50-day SMA	$9.41
50-day SMA vs 200-day SMA	50under200
52-week high	$16.99
52-week high date	2025-11-04
52-week low	$8.50
52-week low date	2026-09-18
5Y price change	-71.95%
5Y return CAGR	-22.45%
5Y total return	-71.95%
6M price change	-18.75%
6M total return	-18.75%
All-time high	$74.44
All-time high date	2019-02-26
All-time low	$5.63
All-time low date	1996-01-26
Average true range (ATR)	$0.36
Average volume	371.6K
Beta (1Y)	0.23
Beta (2Y)	0.94
Beta (5Y)	0.62
Change from 52-week high	-41.08%
Change from 52-week low	17.77%
Change from all-time high	-86.55%
Change from all-time low	77.96%
Change from open	3.41%
Day's gap	-0.31%
Dollar volume	$2.3M
High price	$10.15
Low price	$9.68
Monthly RSI	40.87
Open price	$9.68
Position in 52-week range	70.21%
Premarket change	0%
Premarket close	$9.71
Premarket price	$9.71
Premarket volume	700
Previous close	$9.71
Price vs 150-day SMA	-4.89%
Price vs 20-day SMA	5.47%
Price vs 200-day SMA	-10.2%
Price vs 50-day SMA	6.39%
Relative volume	0.61
RSI	59.73
Sharpe ratio	-0.86
Sharpe ratio (3Y)	0.04
Sharpe ratio (5Y)	-0.41
Sortino ratio	-1.02
Sortino ratio (3Y)	0.19
Sortino ratio (5Y)	-0.44
Volume	225.4K
Weekly RSI	46.43
YTD price change	-33.97%
YTD total return	-33.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40.4M
Float percentage	99.2%
Shares change (QoQ)	1.13%
Shares change (YoY)	3.56%
Shares held by insiders	0.8%
Shares held by institutions	55.24%
Shares outstanding	40.7M
Short % of float	6.04%
Short % of shares	6%
Short ratio	6.1 days

Deeper analysis on OFIX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OFIX report

Is a complete OFIX research report available?

No complete published report is available for Orthofix Medical Inc. (OFIX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Orthofix Medical Inc. (OFIX)

Price

Financial snapshot

Fair-value bridge

Latest news · OFIX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OFIX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OFIX

Frequently asked questions